GO:0000815 ESCRT III complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000815 (ESCRT III complex) is a cellular_component defined by QuickGO as a complex with membrane scission activity that remodels membranes during endosomal transport, nuclear envelope organisation and cytokinesis.
• ESCRT-III assembles into membrane-bound filaments that drive fission and repair of cellular membranes, a function conserved from yeast to humans.
• ESCRT-III is recruited downstream of MLKL during necroptosis and regulates necroptotic cell death and its consequences.
• ESCRT-III repairs nuclear envelope ruptures during cell migration, limiting DNA damage and cell death.
• ESCRT-III contributes to selective autophagy pathways including macromitophagy in yeast and autophagic cell death in breast cancer.
• Dysregulated ESCRT-III is linked to kidney injury, viral nuclear egress, alpha-synuclein aggregation and cancer, making it a tractable target for CRISPR-based models.
Description
The ESCRT III complex (GO:0000815) is a cellular_component with membrane scission activity that plays a major role in many processes where membranes are remodelled, including endosomal transport (vesicle budding), nuclear envelope organisation (membrane closure, mitotic bridge cleavage) and cytokinesis (abscission). Unlike classical endosomal sorting complexes that recognise cargo, ESCRT-III is the terminal membrane-remodelling machine that constricts and severs lipid bilayers. Its activity is required not only for multivesicular body biogenesis but also for repairing wounded plasma and nuclear membranes, for viral budding and for the final abscission step of cell division. Because ESCRT-III sits at the intersection of membrane trafficking, cell death and genome stability, it is a high-value node for both basic cell biology and translational research. Perturbations of ESCRT-III components have been implicated in necroptotic signalling, lysosomal repair after cisplatin injury, herpesvirus nuclear egress, alpha-synuclein proteotoxicity and breast cancer cell death. Researchers therefore need robust, isogenic models to dissect which ESCRT-III subunits are causal in a given phenotype. This article summarises the QuickGO definition, the structural and mechanistic logic of ESCRT-III assembly, the key genes involved, disease links and the CRISPR and multi-omics methods used to study this complex.
ESCRT III complex At A Glance
| GO ID | GO:0000815 |
|---|---|
| GO term | ESCRT III complex |
| Ontology | cellular_component |
| Synonym | endosomal sorting complex required for transport |
| Major function | Membrane scission activity that remodels membranes during endosomal transport, nuclear envelope organisation and cytokinesis |
| Process context | Endosomal transport (vesicle budding), nuclear envelope organisation (membrane closure, mitotic bridge cleavage), cytokinesis (abscission) |
| Conservation | Functionally conserved membrane fission and repair machine from yeast to humans |
| Representative subunits | CHMP2A, CHMP3, CHMP4A/B/C, CHMP5, CHMP6, CHMP7, IST1, VPS4A/B, ALIX, SNF8, VPS25, VPS36 |
| Disease relevance | Necroptosis, acute kidney injury, viral nuclear egress, alpha-synucleinopathy, breast cancer |
What Is GO:0000815?
In our own words, GO:0000815 describes the ESCRT III complex as a membrane-associated protein machine whose core activity is membrane scission. It operates wherever cells must cut or seal a lipid bilayer, including during endosomal vesicle budding, closure and cleavage of the nuclear envelope, and the abscission step of cytokinesis. The QuickGO synonym 'endosomal sorting complex required for transport' reflects its historical discovery in endosomal sorting, but the current definition emphasises its broader membrane-remodelling role.
Why Is ESCRT III complex Important in Cell Biology?
ESCRT-III is important because it is the cell's principal membrane-cutting and membrane-sealing machine, and its dysfunction has consequences that span cell death, genome stability, infection and cancer. Understanding which ESCRT-III subunits are required for a specific membrane-remodelling event is essential for interpreting phenotypes in necroptosis, lysosomal repair, viral egress and autophagy, and for designing therapeutic strategies that either enhance or block membrane scission.
• Defines the terminal membrane scission step of endosomal sorting and multivesicular body formation.
• Repairs nuclear envelope ruptures during cell migration, limiting DNA damage and cell death.
• Acts downstream of MLKL to regulate necroptotic cell death and its consequences.
• Mediates lysosomal repair and improves renal tubular cell injury in cisplatin-induced acute kidney injury.
• Is recruited by human herpesvirus 6A nuclear egress complex to promote nuclear egress of the nucleocapsid.
• Is inhibited by alpha-synuclein aggregates through sequestration and collateral degradation, linking it to synucleinopathies.
• Promotes autophagic cell death in breast cancer when assembled via cytoplasmic YAP1 and is ubiquitinated by NEDD4L.
• Contributes to macromitophagy in yeast, showing conservation of ESCRT-III in selective autophagy.
• Provides a druggable and genetically tractable node for membrane repair and trafficking research.
ESCRT III complex: assembly, structure and mechanism
Initiation and recruitment to membranes
In simple terms: The cell first marks the spot on the membrane where cutting is needed, then calls the ESCRT-III machinery there.
ESCRT-III is recruited to sites of membrane remodelling by upstream factors and adaptors, including ALIX and the ESCRT-I/II machinery, and by specific triggers such as MLKL during necroptosis. In migrating cells, nuclear envelope ruptures recruit ESCRT-III to the damage site to reseal the barrier. In human herpesvirus 6A infection, the viral nuclear egress complex recruits ESCRT-III to promote nuclear egress of the nucleocapsid. These examples show that recruitment is context-dependent and dictated by the membrane-remodelling event.
Polymerisation into membrane-bound filaments
In simple terms: Once recruited, ESCRT-III proteins link together into spiral filaments that constrict the membrane.
Core ESCRT-III subunits such as CHMP4 family proteins polymerise into membrane-bound filaments that bend and constrict lipid bilayers, a step required for membrane fission and repair. In breast cancer cells, cytoplasmic YAP1 promotes ESCRT-III assembly to drive autophagic cell death, and this assembly is counteracted by NEDD4L-mediated ubiquitination. In yeast, ESCRT-III contributes to macromitophagy, indicating that filament assembly is used in selective autophagy contexts as well.
Membrane scission and repair
In simple terms: The ESCRT-III filament tightens and cuts the membrane, or seals a hole in it.
The defining activity of GO:0000815 is membrane scission, which underlies endosomal vesicle budding, nuclear envelope closure and mitotic bridge cleavage, and cytokinesis abscission. ESCRT-III also repairs nuclear envelope ruptures during cell migration, and loss of this repair leads to DNA damage and cell death. In cisplatin-induced acute kidney injury, ESCRT-III-mediated lysosomal repair improves renal tubular cell injury, showing that membrane repair is a physiologically relevant output of this complex.
Disassembly and recycling by VPS4
In simple terms: After the cut is made, the machine is taken apart so it can be reused.
ESCRT-III filaments are disassembled by the AAA-ATPase VPS4, which recycles subunits for subsequent rounds of membrane remodelling. This ATP-dependent step is essential for maintaining a pool of available ESCRT-III subunits and for completing processes such as abscission and nuclear envelope reformation. Perturbations of disassembly can trap ESCRT-III on membranes and impair downstream trafficking and repair events.
Regulation by ubiquitination and protein quality control
In simple terms: The cell uses tags and degradation signals to control how much ESCRT-III is available.
ESCRT-III assembly and turnover are regulated by ubiquitination; for example, NEDD4L ubiquitinates YAP1-driven ESCRT-III assembly in breast cancer, modulating autophagic cell death. Alpha-synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation, providing a pathological mechanism by which protein aggregates impair membrane remodelling. These findings place ESCRT-III under the control of both physiological ubiquitin signalling and proteotoxic stress.
Key Genes Involved in GO:0000815 ESCRT III complex
The following genes and proteins represent the core and accessory components of the ESCRT III complex (GO:0000815) and its regulatory machinery.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CHMP2A | Core ESCRT-III subunit; filament formation and membrane scission | Knockout and point-mutation models to test scission and repair |
| CHMP3 | Core ESCRT-III subunit; membrane constriction | Loss-of-function studies in endosomal sorting and abscission |
| CHMP4A | Core ESCRT-III subunit; polymerisation into filaments | Tagged knock-in for live imaging of filament assembly |
| CHMP4B | Core ESCRT-III subunit; membrane repair and nuclear envelope sealing | KO models for nuclear envelope rupture repair |
| CHMP4C | Core ESCRT-III subunit; abscission and midbody regulation | Point-mutation models for cytokinesis defects |
| CHMP5 | ESCRT-III-associated subunit; endosomal sorting | KO and overexpression for trafficking studies |
| CHMP6 | ESCRT-III subunit; recruitment to membranes | Interaction and recruitment assays |
| CHMP7 | ESCRT-III subunit; nuclear envelope reformation | KO models for nuclear envelope organisation |
| IST1 | ESCRT-III regulator; controls filament disassembly | Knock-in tagging for dynamics studies |
| VPS4A | AAA-ATPase; disassembles ESCRT-III filaments | ATPase-dead point mutants to trap filaments |
| VPS4B | AAA-ATPase; ESCRT-III recycling | KO and point-mutation models |
| ALIX | Adaptor; recruits ESCRT-III to membranes | KO models for cargo recruitment |
| SNF8 | ESCRT-II component; upstream of ESCRT-III | KO models for endosomal sorting |
| VPS25 | ESCRT-II component; upstream of ESCRT-III | KO models for endosomal sorting |
| VPS36 | ESCRT-II component; upstream of ESCRT-III | KO models for endosomal sorting |
| MLKL | Necroptosis effector; recruits ESCRT-III downstream | KO and point-mutation models for necroptosis |
| YAP1 | Promotes ESCRT-III assembly in breast cancer | Overexpression and KO models for autophagic cell death |
| NEDD4L | E3 ubiquitin ligase; ubiquitinates YAP1-driven ESCRT-III assembly | KO and point-mutation models for regulation |
How Is ESCRT III complex Regulated?
ESCRT-III activity is regulated at multiple levels. Recruitment to membranes is controlled by upstream adaptors and triggers such as MLKL during necroptosis and by the viral nuclear egress complex during herpesvirus infection. Assembly is promoted by factors such as cytoplasmic YAP1 in breast cancer and is counteracted by NEDD4L-mediated ubiquitination. Turnover and recycling depend on the AAA-ATPase VPS4. In addition, alpha-synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation, linking proteostasis to ESCRT-III regulation. These layers of control ensure that membrane scission occurs at the right place and time.
ESCRT III complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MLKL | Necroptosis and inflammatory cell death | MLKL KO and point-mutation cell lines with ESCRT-III readouts |
| CHMP4B | Nuclear envelope rupture repair and genome stability | CHMP4B KO cells under migration-induced nuclear deformation |
| CHMP2A/CHMP3 | Lysosomal repair in cisplatin-induced acute kidney injury | Renal tubular cell KO models with cisplatin treatment |
| CHMP4A/CHMP4B | Herpesvirus 6A nuclear egress | Infection of ESCRT-III KO cells with HHV-6A |
| YAP1/NEDD4L | Breast cancer autophagic cell death | YAP1 overexpression and NEDD4L KO breast cancer lines |
ESCRT-III in necroptosis and inflammatory cell death
ESCRT-III acts downstream of MLKL to regulate necroptotic cell death and its consequences, meaning that the complex can modulate how cells die and how that death affects surrounding tissue. This positions ESCRT-III as a modifier of necroptosis-associated inflammation and tissue damage.
ESCRT-III in kidney injury and lysosomal repair
ESCRT III-mediated lysosomal repair improves renal tubular cell injury in cisplatin-induced acute kidney injury, indicating that enhancing ESCRT-III function could protect tubular cells from nephrotoxic stress. This links GO:0000815 directly to a clinically relevant kidney disease model.
ESCRT-III in viral infection and nuclear egress
ESCRT-III is recruited by the human herpesvirus 6A nuclear egress complex to promote nuclear egress of the nucleocapsid, showing that viruses hijack this host membrane-remodelling machine. Targeting ESCRT-III recruitment may therefore influence herpesvirus replication.
ESCRT-III in neurodegeneration and cancer
Alpha-synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation, providing a mechanistic link between synucleinopathy and impaired membrane remodelling. In breast cancer, cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death and is ubiquitinated by NEDD4L, suggesting that ESCRT-III status may influence tumour cell fate.
From ESCRT III complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is CHMP4B required for nuclear envelope repair after migration-induced rupture? | CHMP4B knockout with tagged knock-in rescue |
| Does MLKL recruit ESCRT-III during necroptosis? | MLKL point-mutation and knockout cells with ESCRT-III imaging |
| Can ESCRT-III-mediated lysosomal repair protect renal tubular cells? | CHMP2A/CHMP3 knockout and overexpression in kidney cells |
| How does VPS4A ATPase activity control ESCRT-III disassembly? | VPS4A ATPase-dead point-mutation knock-in |
| Does YAP1-driven ESCRT-III assembly promote autophagic cell death in breast cancer? | YAP1 overexpression and NEDD4L knockout breast cancer models |
| Does alpha-synuclein aggregation impair ESCRT-III function? | Alpha-synuclein overexpression with ESCRT-III tagged knock-in |
How to Study the ESCRT III complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell fluorescence imaging | Recruitment and dynamics of tagged ESCRT-III subunits | Nuclear envelope repair and abscission studies |
| Affinity purification mass spectrometry | ESCRT-III interactome and context-specific partners | Identifying MLKL, ALIX or viral recruitment factors |
| Endosomal sorting reporters | Vesicle budding and cargo sorting efficiency | Assessing ESCRT-III loss-of-function |
| Nuclear envelope integrity assays | Membrane rupture and resealing | Migration-induced DNA damage studies |
| Lysosomal repair assays | Recovery of lysosomal function after injury | Cisplatin-induced acute kidney injury models |
| Autophagy flux analysis | Autophagic cell death and macromitophagy | Breast cancer and yeast models |
| RNA-seq | Transcriptional consequences of ESCRT-III perturbation | Pathway discovery in disease models |
| Proteotoxic stress assays | Effect of aggregates on ESCRT-III function | Alpha-synucleinopathy models |
Live-cell imaging of ESCRT-III dynamics
Tagged knock-in of core subunits such as CHMP4B allows real-time visualisation of ESCRT-III recruitment, polymerisation and disassembly at sites of membrane remodelling. This approach is particularly powerful for studying nuclear envelope repair during cell migration and abscission during cytokinesis.
Proteomics and interactomics
Affinity purification coupled to mass spectrometry can define the ESCRT-III interactome and identify context-specific partners such as MLKL, ALIX or viral nuclear egress proteins. These datasets help assign function to individual subunits and reveal how recruitment is achieved in different membrane-remodelling events.
Functional membrane scission and repair assays
Membrane scission and repair can be measured using endosomal sorting reporters, nuclear envelope integrity assays and lysosomal repair readouts after cisplatin treatment. Combining these assays with ESCRT-III knockout or point-mutation models establishes causality for specific subunits.
Transcriptomic and autophagy flux analysis
RNA-seq and autophagy flux measurements can reveal how ESCRT-III perturbations affect downstream transcriptional programmes and autophagic cell death, as shown in breast cancer models where YAP1-driven ESCRT-III assembly promotes autophagic cell death. Similar approaches can be applied to yeast macromitophagy models.
How CRISPR Can Be Used to Study GO:0000815 ESCRT III complex
Knockout
CRISPR knockout of core ESCRT-III subunits such as CHMP2A, CHMP3, CHMP4B or VPS4A creates isogenic models to test which membrane-remodelling events require the complex. These models are essential for establishing causality in nuclear envelope repair, endosomal sorting and lysosomal repair.
Point Mutation
Point mutations can be introduced into catalytic or interface residues, for example ATPase-dead VPS4A or MLKL mutants, to dissect specific steps of ESCRT-III function without fully removing the protein. Such models are valuable for separating recruitment, polymerisation and disassembly activities.
Knock-in
Tagged knock-in of ESCRT-III subunits enables live imaging and proteomic capture of the endogenous complex, preserving physiological expression levels. This is particularly useful for tracking dynamic recruitment during nuclear envelope rupture repair and cytokinesis.
Overexpression
Overexpression of regulators such as YAP1 or disease-associated proteins such as alpha-synuclein can be used to test how excess or aggregated proteins impact ESCRT-III assembly and function. These models complement knockout approaches by revealing gain-of-function or dominant-negative effects.
How EDITGENE Supports ESCRT III complex Research
Researchers studying ESCRT III complex-related genes often need to determine whether a candidate gene is causally involved in membrane scission, repair or disease phenotypes, and this requires precise, isogenic genetic models rather than correlative observations.
Contact EDITGENE today to design your custom CRISPR model for ESCRT III complex research.
Frequently Asked Questions About ESCRT III complex
What is the ESCRT III complex?
The ESCRT III complex (GO:0000815) is a cellular_component with membrane scission activity that remodels membranes during endosomal transport, nuclear envelope organisation and cytokinesis.
What genes are involved in the ESCRT III complex?
Core and accessory genes include CHMP2A, CHMP3, CHMP4A/B/C, CHMP5, CHMP6, CHMP7, IST1, VPS4A/B, ALIX, SNF8, VPS25 and VPS36.
What does GO:0000815 mean?
GO:0000815 is the Gene Ontology identifier for the ESCRT III complex, a cellular_component defined by membrane scission activity in membrane remodelling.
How does ESCRT-III repair the nuclear envelope?
ESCRT-III is recruited to nuclear envelope ruptures during cell migration, where it reseals the barrier and limits DNA damage and cell death.
Is ESCRT-III involved in necroptosis?
Yes, ESCRT-III acts downstream of MLKL to regulate necroptotic cell death and its consequences.
Can viruses hijack ESCRT-III?
Yes, human herpesvirus 6A recruits ESCRT-III through its nuclear egress complex to promote nuclear egress of the nucleocapsid.
How is ESCRT-III linked to kidney injury?
ESCRT III-mediated lysosomal repair improves renal tubular cell injury in cisplatin-induced acute kidney injury.
What role does ESCRT-III play in cancer?
Cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death in breast cancer and is ubiquitinated by NEDD4L.
How is ESCRT-III regulated?
ESCRT-III is regulated by recruitment factors such as MLKL, by ubiquitination via NEDD4L, by VPS4-mediated disassembly and is inhibited by alpha-synuclein aggregates.
What methods are used to study the ESCRT III complex?
Common methods include live-cell imaging of tagged subunits, affinity purification mass spectrometry, endosomal sorting reporters, nuclear envelope integrity assays, lysosomal repair assays, autophagy flux analysis and RNA-seq.
Conclusion
The ESCRT III complex (GO:0000815) is a conserved membrane scission machine that executes some of the most fundamental remodelling events in the cell, from endosomal vesicle budding to nuclear envelope repair and cytokinesis. Its involvement in necroptosis, kidney injury, viral egress, synucleinopathy and breast cancer highlights its broad physiological and pathological importance. Precise CRISPR models, including knockout, point-mutation, knock-in and overexpression lines, combined with imaging, proteomics and screening approaches, are essential to determine which ESCRT-III subunits are causal in each context and to translate these findings into therapeutic hypotheses.
References
- 1. Burigotto M et al.. 2026. ESCRT-III function in membrane fission and repair.. Nat Rev Mol Cell Biol 27(4):297-315 PMID: 41299081
- 2. Tian Z et al.. 2025. ESCRT III-mediated lysosomal repair improve renal tubular cell injury in cisplatin-induced AKI.. Autophagy 21(9):1927-1944 PMID: 40152606
- 3. Gong YN et al.. 2017. ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences.. Cell 169(2):286-300.e16 PMID: 28388412
- 4. Wu Z et al.. 2021. The ESCRT-III complex contributes to macromitophagy in yeast.. Traffic 22(8):258-273 PMID: 34089296
- 5. Gulijiahani A et al.. 2025. ESCRT-III is recruited by human herpesvirus 6A nuclear egress complex to promote nuclear egress of the nucleocapsid.. J Virol 99(9):e0084425 PMID: 40827914
- 6. Sitron CS et al.. 2025. α-Synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation.. Mol Cell 85(18):3505-3523.e17 PMID: 40934925
- 7. Guo Y et al.. 2023. Cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death and is ubiquitinated by NEDD4L in breast cancer.. Cancer Commun (Lond) 43(5):582-612 PMID: 37005481
- 8. Raab M et al.. 2016. ESCRT III repairs nuclear envelope ruptures during cell migration to limit DNA damage and cell death.. Science 352(6283):359-62 PMID: 27013426
